Matches in SemOpenAlex for { <https://semopenalex.org/work/W2043960674> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2043960674 endingPage "254" @default.
- W2043960674 startingPage "243" @default.
- W2043960674 abstract "We analyzed whether baseline parameters of time-domain and spectrotemporal analysis of a signal-averaged ECG or their changes during Mexiletine therapy can predict the antiarrhythmic efficacy of the drug. On 60 post-MI patients with > 100 ventricular premature beats per hour, signal-averaged ECGs were recorded before and after a constant infusion of Mexiletine (7 mg/kg) for 1 h and again after 4 days of oral Mexiletine therapy (Mexiletine SR, 360 mg twice daily). Spectrotemporal analysis was performed on a fixed analyzed signal duration of QRS-complex and ST-segment of X-, Y-, Z-leads using the temporal window of the rectangular type, measuring signals between 10-20 Hz. Intravenous and oral Mexiletine did not produce significant changes in mean values of any time-domain parameters. However, using informative variables of spectra of the signal-averaged ECG, we managed retrospectively to predict antiarrhythmic efficacy in 92% of the patients. Only certain frequency bands (from the range of the spectra at baseline, 10-120 Hz) were predictive for intravenous Mexiletine efficacy: 40-55 Hz in lead Y (P = 0.0116); 55-70 Hz in leads X and Z (P = 0.0063 and P = 0.0269, respectively); 70-85 Hz in lead Z, (P = 0.0227). When the treatment with intravenous Mexiletine was effective, the baseline power spectrum density was lower than when the drug was ineffective, and vice versa. Moreover, the efficacy of oral Mexiletine can be predicted by power density spectrum at baseline (10-25 Hz in lead Z, P = 0.0210; 70-85 Hz in lead Y, P = 0.0254) and by one of the possible (increased, decreased, unchanged) effects of intravenous Mexiletine on the spectra at frequency bands (70-85 Hz in lead X, P = 0.0432 and 40-120 Hz in lead Z, P = 0.0156). These results show the value of spectrotemporal signal-averaged ECG in selecting a subgroup of post-myocardial infarction patients that may benefit from Mexiletine therapy." @default.
- W2043960674 created "2016-06-24" @default.
- W2043960674 creator A5022308904 @default.
- W2043960674 creator A5025789877 @default.
- W2043960674 creator A5050595098 @default.
- W2043960674 creator A5059665759 @default.
- W2043960674 creator A5062151150 @default.
- W2043960674 creator A5085118145 @default.
- W2043960674 creator A5090240409 @default.
- W2043960674 creator A5090465155 @default.
- W2043960674 date "1994-10-01" @default.
- W2043960674 modified "2023-09-25" @default.
- W2043960674 title "Signal-averaged ECG in prediction of the short-term suppression of ventricular premature beats by Mexiletine" @default.
- W2043960674 cites W1980140122 @default.
- W2043960674 cites W1985024717 @default.
- W2043960674 cites W2000255748 @default.
- W2043960674 cites W2014562798 @default.
- W2043960674 cites W2027464083 @default.
- W2043960674 cites W2049508112 @default.
- W2043960674 cites W2064394177 @default.
- W2043960674 cites W2069519565 @default.
- W2043960674 cites W2071059652 @default.
- W2043960674 cites W2100069431 @default.
- W2043960674 cites W2226722019 @default.
- W2043960674 cites W2289704224 @default.
- W2043960674 cites W2614168425 @default.
- W2043960674 doi "https://doi.org/10.1016/0167-5273(94)90247-x" @default.
- W2043960674 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7529214" @default.
- W2043960674 hasPublicationYear "1994" @default.
- W2043960674 type Work @default.
- W2043960674 sameAs 2043960674 @default.
- W2043960674 citedByCount "2" @default.
- W2043960674 countsByYear W20439606742022 @default.
- W2043960674 crossrefType "journal-article" @default.
- W2043960674 hasAuthorship W2043960674A5022308904 @default.
- W2043960674 hasAuthorship W2043960674A5025789877 @default.
- W2043960674 hasAuthorship W2043960674A5050595098 @default.
- W2043960674 hasAuthorship W2043960674A5059665759 @default.
- W2043960674 hasAuthorship W2043960674A5062151150 @default.
- W2043960674 hasAuthorship W2043960674A5085118145 @default.
- W2043960674 hasAuthorship W2043960674A5090240409 @default.
- W2043960674 hasAuthorship W2043960674A5090465155 @default.
- W2043960674 hasConcept C111773187 @default.
- W2043960674 hasConcept C126322002 @default.
- W2043960674 hasConcept C164705383 @default.
- W2043960674 hasConcept C2777561782 @default.
- W2043960674 hasConcept C2780040984 @default.
- W2043960674 hasConcept C42219234 @default.
- W2043960674 hasConcept C71924100 @default.
- W2043960674 hasConceptScore W2043960674C111773187 @default.
- W2043960674 hasConceptScore W2043960674C126322002 @default.
- W2043960674 hasConceptScore W2043960674C164705383 @default.
- W2043960674 hasConceptScore W2043960674C2777561782 @default.
- W2043960674 hasConceptScore W2043960674C2780040984 @default.
- W2043960674 hasConceptScore W2043960674C42219234 @default.
- W2043960674 hasConceptScore W2043960674C71924100 @default.
- W2043960674 hasIssue "3" @default.
- W2043960674 hasLocation W20439606741 @default.
- W2043960674 hasLocation W20439606742 @default.
- W2043960674 hasOpenAccess W2043960674 @default.
- W2043960674 hasPrimaryLocation W20439606741 @default.
- W2043960674 hasRelatedWork W1971192386 @default.
- W2043960674 hasRelatedWork W1982666179 @default.
- W2043960674 hasRelatedWork W2004436674 @default.
- W2043960674 hasRelatedWork W2074993742 @default.
- W2043960674 hasRelatedWork W2120146913 @default.
- W2043960674 hasRelatedWork W2140392144 @default.
- W2043960674 hasRelatedWork W2162264810 @default.
- W2043960674 hasRelatedWork W2165106783 @default.
- W2043960674 hasRelatedWork W2256587271 @default.
- W2043960674 hasRelatedWork W2471425345 @default.
- W2043960674 hasVolume "46" @default.
- W2043960674 isParatext "false" @default.
- W2043960674 isRetracted "false" @default.
- W2043960674 magId "2043960674" @default.
- W2043960674 workType "article" @default.